HUG-19232-10706
3 vaccinations
9 coded responses
36 check-ins
9 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 652 / MO
- Registered
- 2021-05-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-07
Registered in v-safe
-
2021-05-07
Dose 1 — Pfizer-BioNTech
- 2021-05-07
-
2021-05-08
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-05-09
- 2021-05-10
- 2021-05-11
- 2021-05-12
- 2021-05-14
- 2021-05-21
-
2021-05-28
Survey response — day 21, dose 1MedDRA: Fatigue — Feeling: FairFree text: FatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-31
Dose 2 — Pfizer-BioNTech
-
2021-06-04
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling, Itching · Fatigue or tirednessFree text: Lymph node enlargementMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-05
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain, Swelling · Fatigue or tirednessFree text: LymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-06
-
2021-06-07
Survey response — day 7, dose 2MedDRA: Dizziness — Feeling: GoodFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-14
- 2021-06-21
- 2021-06-28
- 2021-07-07
- 2021-07-12
-
2021-08-31
Survey response — 3 months, dose 2MedDRA: Pregnancy — Feeling: FairFree text: Pregnancy, nausea, fatigueMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-11-29
-
2021-12-10
Dose 3 — Pfizer-BioNTech
-
2021-12-10
Health check-in — day 0, dose 3Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-12-11
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Itching · Fatigue or tirednessAdult check-in
-
2021-12-12
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Itching · HeadacheAdult check-in
-
2021-12-13
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-12-14
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-12-15
-
2021-12-16
Survey response — days 1–6 daily, dose 3MedDRA: Pregnancy — Feeling: Good · Fatigue or tirednessFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2021-12-17
Survey response — day 7, dose 3MedDRA: Pregnancy — Feeling: Good · Fatigue or tirednessFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
- 2021-12-24
- 2021-12-31
- 2022-01-07
- 2022-01-16
- 2022-01-23
-
2022-03-11
Survey response — 3 months, dose 3MedDRA: Gestational hypertension — Feeling: Good · Be unable to work or attend schoolFree text: Gestational hypertensionMedDRA releases: 2024-11 · check-in free text available
-
2022-06-10
Survey response — 6 months, dose 3MedDRA: Anxiety, Delivery, Depression, Foetal hypokinesia, Gestational hypertension, Induced labour, Pain in extremity — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Gestational hypertension Decreased fetal movement Induced vaginal delivery Baby with three weeks of jaundice Leg pain being worked up Depression and anxietyMedDRA releases: 2024-11 · check-in free text available
-
2022-06-10
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
-
2022-06-14
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-12-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-07 | Pfizer-BioNTech | |
| 2 | 2021-05-31 | Pfizer-BioNTech | |
| 3 | 2021-12-10 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 8 — day 21, dose 1
Symptoms: Fatigue
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Lymph node enlargement
Systemic reaction (other): Lymphadenopathy
Release 8 — day 7, dose 2
Systemic reaction (other): Dizziness
Release 9 — 3 months, dose 2
Symptoms: Pregnancy, nausea, fatigue
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Pregnancy
Release 10 — day 7, dose 3
Systemic reaction (other): Pregnancy
Release 11 — 3 months, dose 3
Symptoms: Gestational hypertension
Release 12 — 6 months, dose 3
Symptoms: Gestational hypertension Decreased fetal movement Induced vaginal delivery Baby with three weeks of jaundice Leg pain being worked up Depression and anxiety
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anxiety | · | · | ✓ |
| SD | Delivery | · | · | ✓ |
| SD | Depression | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Foetal hypokinesia | · | · | ✓ |
| SD | Gestational hypertension | · | · | ✓ |
| SD | Induced labour | · | · | ✓ |
| SD | Pain in extremity | · | · | ✓ |
| SD | Pregnancy | ✓ | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release